A universal polysaccharide conjugated vaccine against O111E. coli-Reference-Cited by-同舟云学术

A universal polysaccharide conjugated vaccine against O111E. coli

Published:2014-10-03 Issue:10 Volume:10 Page:2864-2874
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Andrade Gabrielle R¹,New Roger R C²,Sant’Anna Osvaldo A³,Williams Neil A⁴,Alves Rosely C B⁵,Pimenta Daniel C⁶,Vigerelli Hugo⁶,Melo Bruna S¹,Rocha Letícia B¹,Piazza Roxane M F¹,Mendonça-Previato Lucia⁷,Domingos Marta O¹

Affiliation:

1. Laboratory of Bacteriology; Instituto Butantan; São Paulo, Brazil

2. Proxima Concepts Ltd; London, UK

3. Laboratory of Immunochemistry; Instituto Butantan; São Paulo, Brazil

4. Department of Cellular and Molecular Medicine; Bristol University; Bristol, UK

5. Laboratory of Virology; Instituto Butantan; São Paulo, Brazil

6. Laboratory of Biochemistry; Instituto Butantan; São Paulo, Brazil

7. Institute of Biophysics Carlos Chagas; UFRJ; Rio de Janeiro, Brazil

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.4161/21645515.2014.972145

Reference54 articles.

1. Travelersʼ diarrhea

2. Diarrheagenic Escherichia coli

3. Detection and Quantitation of Enterohemorrhagic Escherichia coli O157, O111, and O26 in Beef and Bovine Feces by Real-Time Polymerase Chain Reaction†

4. The Non-O157 Shiga-Toxigenic (Verocytotoxigenic)Escherichia coli; Under-Rated Pathogens

5. Non‐O157 Shiga Toxin–ProducingEscherichia coliInfections in the United States, 1983–2002

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. O26 Polysaccharides as Key Players in Enteropathogenic E. coli Immune Evasion and Vaccine Development;International Journal of Molecular Sciences;2024-03-01

2. Pentavalent outer membrane vesicles immunized mice sera confers passive protection against five prevalent pathotypes of diarrhoeagenic Escherichia coli in neonatal mice;Immunology Letters;2023-11

3. O55 Polysaccharides Are Good Antigen Targets for the Formulation of Vaccines against O55 STEC and Capsulated aEPEC Strains;Pathogens;2022-08-09

4. Genomics and pathotypes of the many faces ofEscherichia coli;FEMS Microbiology Reviews;2022-06-24

5. Recent advances in lipopolysaccharide-based glycoconjugate vaccines;Expert Review of Vaccines;2021-10-25